About this trial
The study aims to verify whether the use of a specific footwear providing increased plantar feedback (plantar feedback shoes) could improve gait parameters, postural control and functional performances in people with Parkinson's disease.
Specifically, the aims are:
* To evaluate the acute effect of plantar feedback shoes, by comparing gait, functional and postural performances in three conditions: neutral shoes, barefoot, and plantar feedback shoes; * To evaluate the effect of four weeks of plantar feedback shoes, on gait, functional and postural performances.
Participants will undergo a comprehensive neurological examination, with administration of disease-specific scales (UPDRS III part 3, NFOG-q, LEDD, DASS-21). At each assessment the participants will perform an inertial gait analysis, a static posturography, and will undergo functional capacity assessments (TUG, 2MWT, 5-STST, 10- mFW).
Eligibility criteria
Qualifiers
Diagnosis of Parkinson's disease, according to the clinical diagnostic criteria of the Movement Disorders Society (Postuma RB, 2015);
Hoehn & Yahr between II and IV;
Stable medical therapy since at least one month before enrollment
Disqualifiers
Concomitant diagnosis of other neurological or psychiatric disorders that may influence study assessments.;
MMSE score <24;
Patients with DBS implant or on DuoDopa therapy;
Presence of relevant musculoskeletal or orthopedic pathologies;
Trial design
Treatments tested in this trial
- Greater plantar feedback shoes
- Neutral gym shoes
- Barefoot